Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8786)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cardinale L, Asteggiano F, Moretti F, Torre F, Ulisciani S, Fava C, Rege-Cambrin G. Pathophysiology, clinical features and radiological findings of differentiation syndrome/all-trans-retinoic acid syndrome. World J Radiol 2014; 6(8): 583-588 [PMID: 25170395 DOI: 10.4329/wjr.v6.i8.583] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v6/i8/583.htm |
| Number | Citing Articles |
| 1 |
Eva Rajha, Sai-Ching Jim Yeung. Oncologic Emergency Medicine. 2021; : 711 doi: 10.1007/978-3-030-67123-5_53
|
| 2 |
Ghazaleh Hoseinzadeh, Zahra Mohammadzadeh, Bahram Chahardouli, Kamran Ali Moghaddam, Seyed Asadollah Mousavi, Azadeh Omidkhoda, Shahrbano Rostami. Do high-mobility group box 1 gene polymorphisms affect the incidence of differentiation syndrome in acute promyelocytic leukemia?. Molecular Biology Reports 2022; 49(7): 5997 doi: 10.1007/s11033-022-07386-1
|
| 3 |
Lanlan Tang, Wenwen Chai, Fanghua Ye, Yan Yu, Lizhi Cao, Minghua Yang, Min Xie, Liangchun Yang. HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK/ERK signaling in acute promyelocytic leukemia cells. Oncotarget 2017; 8(16): 27314 doi: 10.18632/oncotarget.15432
|
| 4 |
Ashley C. Woods, Kelly J. Norsworthy. Differentiation Syndrome in Acute Leukemia: APL and Beyond. Cancers 2023; 15(19): 4767 doi: 10.3390/cancers15194767
|
| 5 |
Yasuo Saijo. Drug-Induced Lung Injury. Respiratory Disease Series: Diagnostic Tools and Disease Managements 2018; : 129 doi: 10.1007/978-981-10-4466-3_10
|
| 6 |
Natthaporn Sasijareonrat, Nikolaus Jahn, Patompong Ungprasert, Weerapat Owattanapanich. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820937008
|
| 7 |
Maliheh Moradzadeh, Alijan Tabarraei, Hamid Reza Sadeghnia, Ahmad Ghorbani, Ashraf Mohamadkhani, Saiedeh Erfanian, Amirhossein Sahebkar. RETRACTED: Kaempferol increases apoptosis in human acute promyelocytic leukemia cells and inhibits multidrug resistance genes. Journal of Cellular Biochemistry 2018; 119(2): 2288 doi: 10.1002/jcb.26391
|
| 8 |
Sayan Sarkar, Priya Ghosh, Anisha Gehani, Niharendu Ghara, Parthasarathi Bhattacharyya. Multidisciplinary corroboration in differentiation syndrome: a case report. Journal of Medical Case Reports 2021; 15(1) doi: 10.1186/s13256-021-02790-w
|
| 9 |
Tatsuya Oki, Yukihiro Nagatani, Wataru Saika, Yoshiyuki Watanabe. Detailed short-term follow-up high-resolution CT series of differentiation syndrome. BMJ Case Reports 2022; 15(1): e242840 doi: 10.1136/bcr-2021-242840
|
| 10 |
Cristina Prata Amendola, Ricardo André Sales Pereira Guedes, Luciana Coelho Sanches. Oncologic Critical Care. 2019; : 1 doi: 10.1007/978-3-319-74698-2_50-1
|
| 11 |
Sai‐Ching J. Yeung, Carmen P. Escalante. Holland‐Frei Cancer Medicine. 2022; : 1 doi: 10.1002/9781119000822.hfcm141.pub2
|
| 12 |
Luis Gorospe Sarasúa, Sofía Ventura-Díaz, Ana María Ayala-Carbonero, Esther Gambí-Pisonero, Adrián Sánchez-Tornero de la Cruz, Lucía Pérez-Lamas, Rosa Mariela Mirambeaux-Villanova, Anabelle Chinea-Rodríguez. Differentiation Syndrome in a Patient With Acute Promyelocytic Leukemia: Importance of Chest CT. Archivos de Bronconeumología (English Edition) 2020; 56(5): 326 doi: 10.1016/j.arbr.2019.11.004
|
| 13 |
Harsh Goel, Rahul Kumar, Pranay Tanwar, Tarun Kumar Upadhyay, Fahad Khan, Pratibha Pandey, Sojin Kang, Myunghan Moon, Jinwon Choi, Min Choi, Moon Nyeo Park, Bonglee Kim, Mohd Saeed. Unraveling the therapeutic potential of natural products in the prevention and treatment of leukemia. Biomedicine & Pharmacotherapy 2023; 160: 114351 doi: 10.1016/j.biopha.2023.114351
|
| 14 |
Amir T. Fathi, Eytan M. Stein, Courtney D. DiNardo, Mark J. Levis, Pau Montesinos, Stéphane de Botton. Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia. American Journal of Hematology 2021; 96(6): 735 doi: 10.1002/ajh.26142
|
| 15 |
Cristina Prata Amendola, Ricardo André Sales Pereira Guedes, Luciana Coelho Sanches. Oncologic Critical Care. 2020; : 593 doi: 10.1007/978-3-319-74588-6_50
|
| 16 |
Priyanka Gowda, Veeranna Shastry, P. S. S. Ranugha, Vinutha Rangappa. Acitretin-induced differentiation syndrome in a case of generalized pustular psoriasis. Indian Journal of Dermatology, Venereology and Leprology 2020; 86(2): 231 doi: 10.4103/ijdvl.IJDVL_318_18
|
| 17 |
Mihail Cotorogea-Simion, Bogdan Pavel, Sebastian Isac, Teodora Telecan, Irina-Mihaela Matache, Anca Bobirca, Florin-Teodor Bobirca, Razvan Rababoc, Gabriela Droc. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina 2022; 58(9): 1215 doi: 10.3390/medicina58091215
|
| 18 |
Danielle Golub, Nishanth Iyengar, Siddhant Dogra, Taylor Wong, Devin Bready, Karen Tang, Aram S. Modrek, Dimitris G. Placantonakis. Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00417
|
| 19 |
Mohammad Amin Moosavi, Mojgan Djavaheri-Mergny. Autophagy: New Insights into Mechanisms of Action and Resistance of Treatment in Acute Promyelocytic leukemia. International Journal of Molecular Sciences 2019; 20(14): 3559 doi: 10.3390/ijms20143559
|
| 20 |
Bhoomika Sukhadia, Dean Tan, Youjin Oh, Zunairah Shah, Young Kwang Chae. Differentiation Syndrome in a Patient With NSCLC Harboring IDH2 Mutation Treated With Enasidenib: Case Report. JTO Clinical and Research Reports 2024; 5(10): 100520 doi: 10.1016/j.jtocrr.2023.100520
|
| 21 |
Esther S. Kim. Enasidenib: First Global Approval. Drugs 2017; 77(15): 1705 doi: 10.1007/s40265-017-0813-2
|
| 22 |
Luis Gorospe Sarasúa, Sofía Ventura-Díaz, Ana María Ayala-Carbonero, Esther Gambí-Pisonero, Adrián Sánchez-Tornero de la Cruz, Lucía Pérez-Lamas, Rosa Mariela Mirambeaux-Villanova, Anabelle Chinea-Rodríguez. Síndrome de diferenciación en paciente con leucemia promielocítica aguda: importancia de la TC de tórax. Archivos de Bronconeumología 2020; 56(5): 326 doi: 10.1016/j.arbres.2019.11.004
|
| 23 |
Ekta Dhamija, Pankaj Meena, Vidyasagar Ramalingam, Ranjeet Sahoo, Sameer Rastogi, Sanjay Thulkar. Chemotherapy-induced pulmonary complications in cancer: Significance of clinicoradiological correlation. Indian Journal of Radiology and Imaging 2020; 30(01): 20 doi: 10.4103/ijri.IJRI_178_19
|
| 24 |
Fulvio Massaro, Matteo Molica, Massimo Breccia. Current First- and Second-Line Treatment Options in Acute Promyelocytic Leukemia. International Journal of Hematologic Oncology 2016; 5(3): 105 doi: 10.2217/ijh-2016-0010
|
| 25 |
Mohsin Shah, Eva Rajha, Courtney DiNardo, Erin Muckey, William G. Wierda, Sai-Ching J. Yeung. Adverse Events of Novel Therapies for Hematologic Malignancies: What Emergency Physicians Should Know. Annals of Emergency Medicine 2020; 75(2): 264 doi: 10.1016/j.annemergmed.2019.07.015
|